Wiley Displays Commitment to Research and Learning in India
John Wiley and Sons Inc, today announced that Peter Booth Wiley (Chairman Emeritus, Wiley), Matthew Kissner (Chairman of the Board, Wiley) and Vikas Gupta (Managing Director of Wiley, India), will discuss the future of research and learning in India at the 32nd International Publishers Association (IPA) Congress to be held in New Delhi from February 11 to 13, 2018. The company’s top leaders will discuss opportunities to build science, technology, engineering and mathematics (STEM) capacity in India. “We have been publishing books and scholarly material in India since the 1960s,” said Mr. Peter Booth Wiley, of the company that bears his name. “Each year our editors review more than 25,000 submissions from Indian authors and we are committed to grow the quantity and quality of those scientific articles, helping to transform the country into a science hub.” Mr. Matthew Kissner added, “We have an opportunity to support the transformation of India into an R&D powerhouse and home to a STEM workforce that drives global change. In partnership with representatives from government, corporate and academic institutes, Wiley plans to expand the validation and communication of top research in India and develop high-quality educational content to help build a workforce equipped with the skills necessary to inform science well into the future.” Local needs are global needs and as the world’s largest partner to non-profit sci...
Publication date: Available online 20 October 2018Source: Urology Case ReportsAuthor(s): Y. Ayari
Publication date: Available online 20 October 2018Source: Urology Case ReportsAuthor(s): Vincent Khor, LIE Kwok Ying
In this report, we looked at opioid medication use following discharge after radical prostatectomy. We found that 77% of opioid pain medication prescribed was unused, with 84% of patients using less than half of their prescription. Prescribing more opioids was associated with greater use; only 9% of patients appropriately disposed of leftover medication.
Authors: Voulgaris A, Nena E, Steiropoulos P PMID: 30338831 [PubMed - in process]
Authors: Fisichella R, Benfatto S, Berretta S PMID: 30338830 [PubMed - in process]
Authors: Pintaudi B, Di Vieste G, Corrado F, Lucisano G, Giunta L, D'Anna R, Di Benedetto A Abstract OBJECTIVE: Myo-inositol supplementation prevents gestational diabetes (GDM) in women at risk and reduces insulin resistance in women with GDM. No data are available about its effect on glucose variability. The aim of this study was to evaluate the effects of a supplementation of myo-inositol on glucose variability in women with GDM. PATIENTS AND METHODS: Myo-inositol effect on glucose variability was studied in a pilot case-control study involving 12 consecutive pregnant women (median age 34 years, 25.0% insulin...
CONCLUSIONS: MiR-124 down-regulation was associated with renal cancer cell OS-RC-2 invasion enhancement. Over-expression of miR-124 attenuated OS-RC-2 cell invasion by down-regulating STAT3 and MMP-9. PMID: 30338828 [PubMed - in process]
CONCLUSIONS: We found that the majority of human milk samples included beta-lactams or quinolones, even though the mothers did not receive these antibiotics during pregnancy and lactation. Antibiotic residues in human milk may affect early maintenance of the intestinal microbiota. Previous studies have shown that antimicrobials in food might increase the risks of allergies and could lead to the development of antibiotic-resistant bacterial strains. Effective policies on food safety and appropriate antibiotic use during pregnancy and lactation are needed. PMID: 30338827 [PubMed - in process]
CONCLUSIONS: Cyclosporine protects HK-2 cells from inflammatory injury via regulating mTOR pathway. PMID: 30338826 [PubMed - in process]
Authors: Golino M, Spera FR, Manfredonia L, De Vita A, Di Franco A, Lamendola P, Villano A, Melita V, Mencarelli E, Lanza GA, Crea F Abstract OBJECTIVE: About one-third of patients undergoing percutaneous coronary interventions (PCIs) for flow-limiting coronary stenosis continue to develop signs of myocardial ischemia (MI) during exercise stress test [EST], despite successful coronary revascularization. Coronary microvascular dysfunction is a likely major cause of the persistence of EST-induced MI in these patients. PATIENTS AND METHODS: We studied 15 patients (14 men, age 67±5 years) fulfilling the foll...